About UsAbout Us
The Photolysis Consortium
The PHOTOLYSIS consortium comprises 9 partner institutions from five European countries including three small and medium size enterprises (SME). The Coordinator is CNRS, the French National Council for Scientific Research.
The PHOTOLYSIS consortium comprises 9 partner institutions from five European countries including three small and medium size enterprises (SME). The Coordinator is CNRS, the French National Council for Scientific Research.
PHOTOLYSIS was launched in March 2007 and will run for a period of three years.
The consortium is a multi-disciplinary network, integrating research programmes in Neuroscience, Synthetic Chemistry and Photochemistry, Photonics and Microscopy, HTS patch clamp technology and molecular biology applied to ion channels in somatic cell therapy. Postgraduate Workshops are supported as part of the programme.
CNRS
Centre National de la Recherche Scientifique, CNRS, ParisPHOTOLYSIS Principal Investigator: David Ogden
INSERM
Inserm is the French public research body entirely dedicated to human health. Its researchers are committed to studying all diseases, whether common or rare, through their research in the fields of biology, medicine and public health.
PHOTOLYSIS Principal Investigators : Serge Charpak and Valentina Emiliani
University of Strathclyde
Centre for Biophotonics, University of StrathclydeThe Centre for Biophotonics was created to foster world class interdisciplinary research between life scientists and physicists in the area of high-resolution optical imaging. The primary objective is to create an internationally recognised centre of excellence for the development and application of novel optical techniques in the life sciences.
PHOTOLYSIS Principal Investigator: Gail McConnell
Department of Physics, University of Strathclyde
The Department of Physics has strengths in both research and in teaching. There is presently about 300 undergraduate students, while the annual research turnover is about £4M. This makes us one of the bigger physics departments in Scotland, and one of the biggest research departments at the University of Strathclyde. The Department of Physics is also a member of SUPA, the Scottish Universities Physics Alliance.
The Department of Physics has strengths in both research and in teaching. There is presently about 300 undergraduate students, while the annual research turnover is about £4M. This makes us one of the bigger physics departments in Scotland, and one of the biggest research departments at the University of Strathclyde. The Department of Physics is also a member of SUPA, the Scottish Universities Physics Alliance.
PHOTOLYSIS Principal Investigator: Erling Riis
Flyion GmbH
flyion GmbH is a solutions provider for ion channel research in drug discovery and safety pharmacology. The company’s automated and semi-automated patch clamp devices are based on its patented Flip-the-Tip™ technology. Complementary services are available for ion channel screening and for assay and cell line development.
Über flyion:
flyion GmbH entwickelt automatisierte Patch Clamp Geräte für die Ionenkanalforschung. Diese basieren auf dem patentierten Flip-the-Tip™ Verfahren, bei dem das Patch Clamp Experiment im Inneren einer regulären Glasspipette durchgeführt wird. Die Geräte werden zur Charakterisierung von Ionenkanälen, zum Screening von Wirkstoffkandidaten, sowie für sicherheitspharmakologische Untersuchungen eingesetzt. Zur Unterstützung seiner Kunden bietet flyion auch das Ionenkanal Screening und die Entwicklung von Assays und Zelllinien als Dienstleistungen an.
PHOTOLYSIS Principal Investigator: Albrecht Lepple-Wienhues
Tocris Bioscience
Tocris Bioscience is a leading supplier of high performance chemicals, peptides and antibodies, with customers in virtually all of the worlds' major pharmaceutical companies, universities and research institutes. The Company is committed to making new life science discoveries possible by providing the most innovative range of high purity research reagents. The Company's catalogue of over 1,800 reagents represents a unique collection of novel, exclusive and licensed research tools, and is sent to more than 50,000 scientists worldwide annually. Tocris Bioscience products are used by scientists carrying out non-clinical research in fields such as cardiovascular disease, cancer, pain, inflammation, and neurological disorders. Our range includes GPCR ligands, neurotransmitters, ion channel modulators, signalling inhibitors and more.Photolysis Principal Investigator: Duncan Crawford
Academy of Science of the Czech Republic
Academy of Science of the Czech Republic, Prague
The Academy is a public non-university scientific institution of the Czech Republic encompassing a complex of research institutes engaged primarily in basic research.
ASCR formulates and pursues conceptual policy of science and research, participates in national and international research programmes, promotes cooperation with application sphere, and fosters the development of education, scholarship and culture.
The Academy of Sciences of the Czech Republic (AS CR) was established by Act No. 283/1992 Coll. as the Czech successor of the former Czechoslovak Academy of Sciences. It is set up as a complex of 53 public research institutions. The Academy employs about 7,000 employees more than a half of whom are researchers with university degrees.
The Academy is a public non-university scientific institution of the Czech Republic encompassing a complex of research institutes engaged primarily in basic research.ASCR formulates and pursues conceptual policy of science and research, participates in national and international research programmes, promotes cooperation with application sphere, and fosters the development of education, scholarship and culture.
The Academy of Sciences of the Czech Republic (AS CR) was established by Act No. 283/1992 Coll. as the Czech successor of the former Czechoslovak Academy of Sciences. It is set up as a complex of 53 public research institutions. The Academy employs about 7,000 employees more than a half of whom are researchers with university degrees.
PHOTOLYSIS Principal Investigator: Ladislav Vyklicky
GeneGrafts LTD
GeneGrafts was founded in Nov. 2003 by Dr. Yair Feld, Prof. Lior Gepstein, Prof. Shimon Marom and Dr. Meira Melamed-Frank, as a spin-off of the Technion – Israel Institute of Technology (Haifa, Israel). GeneGrafts is a biotechnology company developing proprietary technology for modulating excitable tissues (e.g. Brain, Heart) by transplantation of cells overexpressing ion channels. This new paradigm can be used for the treatment of various diseases including Parkinson’s disease and other neurological disorders, and cardiac arrhythmias.PHOTOLYSIS Principal Investigator: Yair Feld
Inserm Transfert
Inserm Transfert, a private subsidary of Inserm, is involved in the activities of intellectual property management, technology transfer and industrial partnerships. The goal is to shorten the time span between laborator discoveries and the development of new health for patients.PHOTOLYSIS Project Manager: Isabelle Geahel